Cargando…
Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study
BACKGROUND: Statins have, due to their anti-inflammatory properties, been suggested to potentially improve chronic obstructive pulmonary disease (COPD) outcomes. We aimed to investigate the effect of statins on time to first exacerbation and all-cause mortality in high-risk COPD outpatients. METHODS...
Autores principales: | Damkjær, Mathias, Håkansson, Kjell, Kallemose, Thomas, Ulrik, Charlotte Suppli, Godtfredsen, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943323/ https://www.ncbi.nlm.nih.gov/pubmed/33707941 http://dx.doi.org/10.2147/COPD.S296472 |
Ejemplares similares
-
Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study
por: Damkjær, Mathias, et al.
Publicado: (2021) -
Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study [Corrigendum]
Publicado: (2021) -
Pulmonary telerehabilitation vs. conventional pulmonary rehabilitation – a secondary responder analysis
por: Hansen, Henrik, et al.
Publicado: (2023) -
The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
por: Håkansson, K. E. J., et al.
Publicado: (2019) -
High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020)